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ABSTRACT: Tertiary benzylic stereocenters are accessed in high 
enantioselectivity by Ir-catalyzed branch selective addition of ani-
lide ortho-C-H bonds across styrenes and α-olefins. Mechanistic 
studies indicate that the stereocenter generating step is reversible. 
Tertiary benzylic stereocenters are of recognized value in the de-
sign of pharmaceuticals (Scheme 1A). The most powerful method-
ologies to access these motifs establish the stereocenter via a C-C 
bond forming fragment union step.1 Commonly, this is achieved by 
cross-coupling of a nucleophile with an electrophile,2 however, ef-
fective methods that harness two electrophiles3 or two nucleophiles 
have also emerged.4 Recent methods that allow the direct use of 
alkenes as a coupling partner are notable.5 Arguably, the most gen-
eral approaches exploit arylation of stereodefined secondary alkyl 
boronic acid derivatives (Scheme 1B).2a,c,g,h,4 Within this context, 
Pd-catalyzed Suzuki couplings with aryl halides have been devel-
oped; however, isomerization of the alkyl-Pd(II) intermediate often 
leads to isomeric products.1a,b,2a,g,h Metal-free cross-couplings of 
aryl lithium reagents with alkyl boronic esters, which require ex-
ternal oxidants, circumvent this problem and offer good scope.4 For 
all of these approaches, step and atom economy are imperfect be-
cause of the requirement for prefunctionalization and/or the need 
for additional reagents in the coupling step. For example, alkyl bo-
ronic esters are often accessed by enantioselective hydroboration 
of an alkene precursor,6 whereas aryl halides are usually prepared 
by regioselective halogenation of an aryl C-H bond.  
The fact that alkenes and aryl C-H bonds can be considered feed-
stock precursors for the approaches summarized in Scheme 1B 
raises the question of whether tertiary benzylic stereocenters might 
be accessed directly via C-H activation-triggered enantioselective 
addition of an aryl C-H bond across an alkene. In this context, the 
most challenging processes are likely to be those that harness non-
polarized acyclic alkenes (i.e. styrenes and α-olefins), because 
these offer minimal electronic control for achieving regioselective 
C-C bond formation. Indeed, synthetically useful intermolecular 
enantioselective alkene hydroarylations invariably exploit polar-
ized alkenes to enforce regiocontrol.7,8,9 Enantioselective alkene 
hydroheteroarylations have also been developed under a range of 
mechanistic regimes, but are limited to specific classes of het-
eroarene or alkene.7a,10 To our knowledge, no general protocol ex-
ists for the highly enantioselective addition of aryl C-H bonds 
across styrenes and α-olefins. 
Building on seminal studies from Togni,7c,d Shibata11a and 
Krische,11b we previously identified Ir-catalysts that overturn the 
usual linear selectivity of Murai-type alkene hydroarylation reac-
tions to provide branched products (Scheme 1C).7a,12,13 Here, 
Scheme 1.  
 
cationic systems modified with dFppb, a wide bite angle and elec-
tron poor achiral bisphosphine ligand, were effective for branch se-
lective hydroarylations of styrenes and α-olefins, whereas narrow 
bite angle ligands (e.g. dppm) afforded linear products.13 The effi-
cacy of these methods provided the impetus for the development of 
enantioselective variants.14 In particular, anilide-based processes 
emerged as a key objective because (a) a large number of anilines 
are commercially available at low cost and (b) derivatizations of 
the products can be achieved via the anilide unit. However, the de-
velopment of an enantioselective alkene hydroarylation process 
was considered challenging because of the prescriptive ligand fea-
tures required for achieving high branch selectivity. As described 
below, we have now succeeded in identifying a modular ligand 
family that allows alkene hydroarylation of styrenes and α-olefins 
to be used for the efficient and highly enantioselective synthesis of 
tertiary benzylic stereocenters.  
We began by undertaking an exhaustive screen of commercially 
available chiral ligands for the hydroarylation of styrene with acet-
 anilide 1a. These studies failed to reveal a system that could pro-
vide both high enantioselectivity and high branched to linear (B:L) 
regioselectivity, with the most promising results shown in Table 1, 
Entries 1-4. Accordingly, a library of new chiral ligands was re-
quired, and we were drawn to variants of Kelliphite15 because the 
modularity of this system leads to general structure L, where one 
or both of the blue and red components is a homochiral unit. An 
attractive feature of this design is that it allows tuning of the ligand 
substructure to provide an effective system for any given substrate. 
For the conversion of 1b to 2b, this approach led initially to 
BiPhePhos-like16 ligand L-1, which afforded 2b in 90:10 e.r., >25:1 
B:L selectivity and 99% yield. Further refinement was sought by 
altering the blue BINOL unit of L-1 and we found that L-3, which 
contains a conformationally flexible biphenol moiety,17 generated 
2b in 92:8 e.r. Here, increased enantioselectivity was observed us-
ing higher dilution (Entry 7 vs 8). Further studies revealed that t-
Bu-substituted variant L-5 could generate 2b in 96:4 e.r. and high 
B:L selectivity using toluene as solvent (Entry 14). L-5 is a novel, 
bench stable bisphosphite ligand that can be prepared in two steps. 
 
Table 1. Optimization of an enantioselective alkene hy-
droarylation process using a modular ligand design. 
 
 
 
As outlined in Table 2A, the method tolerates a wide range of 
interesting and sensitive acetanilides, including indole-based sys-
tem 2e and halogen-substituted systems 2l and 2m. For anilides 
with two available ortho-positions competing bis-ortho-alkylation 
was observed in certain cases using 250 mol% styrene (e.g. 2c), but 
high selectivity for mono-ortho-alkylation was achieved by using 
110 mol% of this component. C-C bond formation is highly selec-
tive for the less hindered ortho-position of meta-substituted sub-
strates (e.g. 2g), which presumably reflects the steric demands of 
the ligand. The reaction conditions tolerate protic functionality (2i), 
and can be extended to elaborate substrates, such as steroid-derived 
system 2ac (Table 2D). The protocol offers good scope with respect 
to the styrene component (Table 2B), with para- (2q) and meta-
substituted systems (e.g. 2r) participating efficiently. Hydroaryla-
tion of ortho-substituted styrenes is more demanding but adduct 2p 
was still formed in 53% yield. Significantly, the process extends to 
α-olefins (Table 2C), as demonstrated by the hydroarylation of hex-
1-ene, which provided 2t in 96% yield and 94:6 e.r. Even very ste-
rically demanding alkenes are tolerated, such that hydroarylation of 
tert-butylethylene led to 2aa in 81% yield and 95:5 e.r. The abso-
lute stereochemistry of 2b was determined by X-ray analysis of (+)-
CSA salt 2b’’ and stereochemical assignments of the other products 
were tentatively made on this basis. 
The scalability of the process is demonstrated by the hydroaryla-
tion of styrene (250 mol%) with 1f on 2 mmol scale, which formed 
2f in 88% yield and 98.5:1.5 e.r. using only 0.25 mol% Ir-catalyst 
(Table 2E). Similarly, 1.61 g of 2b was prepared with satisfactory 
levels of efficiency on a 10 mmol scale. In these examples, the 
lower catalyst loading (vs Table 2A) allowed the processes to be 
run at higher concentration with respect to the substrate (1.0 M vs 
0.05 M), whilst maintaining the same concentration with respect to 
the catalyst. The protocol also tolerates low level contaminants: hy-
droarylation of styrene with pharmacy grade anilide 1i, sourced di-
rectly from acetaminophen (paracetamol) tablets, gave 2i in 
91.5:8.5 e.r. This result, although less efficient than from pure 1i, 
shows that the conditions are tolerant to additives (e.g. magnesium 
stearate) used in the commercial formulation process. Finally, ma-
nipulation of the anilide unit of the products allows easy access to 
heterocycles (3 and 4), iodoarenes (7) and cross-coupled products 
(6) (Table 2F). The results in Table 2 show that the protocol offers 
very good levels of scope for enantioselective hydroarylations of 
styrenes and α-olefins. Another significant aspect is that the method 
provides a formal enantioselective alternative to Friedel-Crafts al-
kylation. Processes of this type are highly challenging, even with-
out factoring in other issues that our method addresses, such as or-
tho vs para regiocontrol and high monoalkylation selectivity.18 
A series of experiments have led to the mechanistic outline given 
in Scheme 2D. As supported by deuterium exchange experiments 
(see the SI), the process likely commences with reversible N-acetyl 
directed C-H oxidative addition to form III. From IV, reversible 
hydrometallation generates linear and branched intermediates V 
and VI; exposure of styrene deuterio-9 to optimized reaction con-
ditions resulted in scrambling of the deuterium labels in product 
deuterio-2q and recovered deuterio-9 (Scheme 2A). C-C bond for-
mation could occur either via C-C reductive elimination from VI 
or via carbometallation from π-complex IV. Support for the latter 
is provided by the observations that (a) bulky alkene substituents 
are tolerated (cf. 2aa) and (b) trace amounts (1-5%) of C-H vinyl-
ation adducts (cf. VII) form in certain cases; these are most easily 
rationalized by invoking β-hydride elimination from carbometalla-
tion product VIII. Natural abundance 13C KIE experiments have 
been used to distinguish unequivocally between C-C reductive 
elimination and carbometallation pathways;19 this method shows 
which alkene carbon-centers are involved in the first irreversible 
step. When the hydroarylation of styrene 9 (100 mol%) with acet-
anilide 1f (150 mol%) was run to approximately 75% conversion, 
analysis of recovered 9 revealed a significant KIE at the terminal 
alkene carbon only (Scheme 2B). This effectively discounts C-C 
reductive elimination as the productive pathway, while indicating 
that (a) C-H reductive elimination is the first irreversible step and 
(b) carbometallation from IV to VIII is reversible. To gain further  
 Table 2. Scope of the enantioselective alkene hydroarylation process.a  
 
 
a Alkene equivalents and branched to linear selectivities are indicated in parentheses (determined by 1H NMR analysis of the crude mixture); 
b Ortho-regioselectivity was 93:7; c The reaction was performed at 120 °C; d Concentration was 0.025 M. 
evidence, we sought to generate intermediate VIII via a distinct 
pathway. To this end, we exposed alkene 10 (cf. VII) to optimized 
conditions, but under an atmosphere of hydrogen on the presump-
tion that hydrometallation by an in situ generated iridium-dihydride 
species would provide an intermediate akin to VIII.20 This experi-
ment generated 2f (6% e.e.) and anilide 1f in a 3:2 ratio (Scheme 
2C). The formation of 1f seemingly confirms that the stereocenter 
generating carbometallation step (IV to VIII) is reversible; this is 
 rather unusual given that high enantioselectivity is observed in Ta-
ble 2. Two mechanistic extremes can account for this. In one sce-
nario, alkene carbometallation (IV to VIII) exhibits low facial se-
lectivity but C-H reductive elimination to the major enantiomer is 
faster than to the minor. In the second scenario, carbometallation 
facial selectivity is high and subsequent C-H reductive elimination 
has a similar energy barrier for both enantiomers. The low enanti-
oselectivity obtained for product 2f in Scheme 2C supports the sec-
ond option, although this interpretation assumes that reduction of 
10 proceeds solely via intermediates of type VIII. The mechanism 
in Scheme 2D is distinct from that proposed in our earlier work 
using dFppb,13b where 13C KIE experiments are suggestive of a C-
C reductive elimination pathway (see the SI). 
 
Scheme 2. Mechanistic studies. 
 
 
A key feature of the ligand design outlined here is that its modu-
larity allows tailoring to specific substrate classes. To demonstrate 
this, we optimized the hydroheteroarylation of styrene with thio-
phene 11a to provide 12a; this process performed poorly using L-
5 (44% yield, >25:1 B:L, 26:74 e.r.) (Table 3) and the low enanti-
oselectivity necessitated a redesign of the ligand system. In the 
event, we found that ferrocene-based bisphosphonite systems in-
corporating SPINOL-derived units as the blue component are ef-
fective. Ligand L-6 (R = H) provided 12a in 77% yield, >25:1 B:L 
selectivity and 91:9 e.r. Substituted variants L-7 (R = Ph) and L-8 
(R = mesityl) can be accessed via earlier stage Suzuki cross-cou-
pling. The latter offered increased selectivity, with 12a formed in 
77% yield and 97.5:2.5 e.r. using 120 mol% styrene. This new lig-
and was applied to thiophenes 12b-f, with satisfactory results 
achieved for hydroarylations of styrenes and α-olefins, and in the 
diastereoselective hydroarylation that forms steroid derivative 12g. 
The absolute stereochemistry of 12a was determined by X-ray dif-
fraction, and other assignments were tentatively made on this basis. 
These results indicate that the broad ligand design in Table 1 will 
facilitate enantioselective alkene hydroarylations across a diverse 
range of substrates. Studies into this aspect are ongoing. 
 
Table 3. Reoptimization for a challenging substrate class.  
 
 
In summary, catalyst systems that promote highly branch selec-
tive and enantioselective hydroarylations of styrenes and α-olefins 
are described. Thus, tertiary benzylic stereocenters are generated 
directly and with complete atom economy. The method simplifies 
access to this important structural motif because prefunctionaliza-
tion of the reaction partners is avoided. Further evolution of our 
approach will include processes that harness other classes of direct-
ing group and more highly substituted alkene partners.  
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